Millions lose access to free NHS earwax removal
Patients unable to afford private treatment are turning to “dangerous self-removal methods”, the RNID says.
Similar Posts
Do you need a prostate check? King Charles III raises awareness of common men’s health condition
Even kings have prostate problems. King Charles III was admitted on Friday to The London Clinic, a private hospital, where he underwent a scheduled procedure due to an enlarged prostate, Buckingham Palace confirmed. The treatment was successful and the king is “doing quite well,” a royal source told Fox News Digital. The palace emphasized that…
Florida wins first FDA approval to import cheaper drugs from Canada
Pharmacist Thomas Jensen looks over a prescription drug at the Rock Canyon Pharmacy in Provo, Utah, on May 9, 2019. George Frey | Reuters The U.S. Food and Drug Administration on Friday approved Florida’s plan to import cheaper prescription drugs from Canada, a first-in-the-nation move that could reduce costs for Americans but faces fierce opposition…
Footballer Michael Owen on sight loss: 'I'd swap eyes with my son if I could'
The father and son on getting to grips with a degenerative eye condition.
These 8 health screenings should be on your calendar for 2024, according to doctors
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Alarming rise in measles in Europe – health chiefs
Urgent measures are needed now to stop further spread, the World Health Organization says.
Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024
For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers Novo Nordisk and Eli Lilly might use the same term for the returns they’ve realized over the past year. U.S.-listed shares of Novo Nordisk, the maker…